Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow Reinvestment Rate
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Reinvestment Rate of 1.47x as of September 2025, reinvesting CN¥414.56 Million (capex CN¥414.56 Million ) from operating cash flow of CN¥282.81 Million. Check Zhejiang Huahai Pharmaceutical Co Ltd (600521) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Explore Zhejiang Huahai Pharmaceutical Co Ltd (600521) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Huahai Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.05 Billion | CN¥1.23 Billion | CN¥1.97 Billion | ▲ +88.5% |
| 2024 | 0.89x | CN¥1.93 Billion | CN¥2.17 Billion | CN¥1.85 Billion | ▼ -38.9% |
| 2023 | 1.45x | CN¥3.22 Billion | CN¥2.22 Billion | CN¥1.59 Billion | ▼ -62.1% |
| 2022 | 3.82x | CN¥4.75 Billion | CN¥1.24 Billion | CN¥2.32 Billion | ▲ +43.9% |
| 2021 | 2.66x | CN¥2.49 Billion | CN¥938.43 Million | CN¥2.43 Billion | ▲ +197.2% |
| 2020 | 0.89x | CN¥1.39 Billion | CN¥1.56 Billion | CN¥1.28 Billion | ▲ +95.6% |
| 2019 | 0.46x | CN¥801.28 Million | CN¥1.75 Billion | CN¥794.31 Million | ▼ -97.5% |
| 2018 | 18.56x | CN¥1.26 Billion | CN¥67.90 Million | CN¥1.12 Billion | ▲ +787.1% |
| 2017 | 2.09x | CN¥1.14 Billion | CN¥546.24 Million | CN¥794.54 Million | ▲ +21.5% |
| 2016 | 1.72x | CN¥746.05 Million | CN¥433.10 Million | CN¥732.88 Million | ▼ -52.3% |
| 2015 | 3.61x | CN¥705.17 Million | CN¥195.31 Million | CN¥524.28 Million | ▲ +171.5% |
| 2014 | 1.33x | CN¥437.06 Million | CN¥328.61 Million | CN¥437.06 Million | ▲ +39.9% |
| 2013 | 0.95x | CN¥466.24 Million | CN¥490.29 Million | CN¥466.24 Million | ▼ -48.2% |
| 2012 | 1.84x | CN¥447.81 Million | CN¥243.83 Million | CN¥447.81 Million | ▲ +4.8% |
| 2011 | 1.75x | CN¥346.06 Million | CN¥197.51 Million | CN¥346.06 Million | ▲ +92.6% |
| 2010 | 0.91x | CN¥272.44 Million | CN¥299.47 Million | CN¥272.44 Million | ▲ +120.8% |
| 2009 | 0.41x | CN¥130.81 Million | CN¥317.44 Million | CN¥130.81 Million | ▼ -75.0% |
| 2008 | 1.65x | CN¥138.89 Million | CN¥84.20 Million | CN¥138.89 Million | ▲ +86.8% |
| 2007 | 0.88x | CN¥120.54 Million | CN¥136.52 Million | CN¥120.54 Million | ▼ -50.5% |
| 2006 | 1.78x | CN¥138.27 Million | CN¥77.54 Million | CN¥138.27 Million | ▼ -61.9% |
| 2005 | 4.67x | CN¥249.14 Million | CN¥53.30 Million | CN¥249.14 Million | ▲ +540.6% |
| 2004 | 0.73x | CN¥119.47 Million | CN¥163.73 Million | CN¥119.47 Million | ▼ -26.6% |
| 2003 | 0.99x | CN¥47.13 Million | CN¥47.41 Million | CN¥47.13 Million | ▲ +54.1% |
| 2002 | 0.65x | CN¥48.60 Million | CN¥75.34 Million | CN¥48.60 Million | ▼ -33.1% |
| 2001 | 0.96x | CN¥36.14 Million | CN¥37.51 Million | CN¥36.14 Million | — |